BioSpace News Archive

Business

Epigenomics AG Reports Financial Results for the First Nine Months 2019

Epigenomics AG announced its financial results for the first nine months of 2019.

November 19, 2019
·
4 min read
Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies

Zelluna Immunotherapy, a biopharma company developing T-cell receptor guided adoptive cell therapy products for the treatment of multiple solid cancers, and Glycostem Therapeutics BV, announce that they have entered into a development, license and supply agreement.

November 19, 2019
·
4 min read
BioCity UK Life Science Start-Up Report reveals a ‘baby boom’ of new life science ventures driven by unprecedented levels of investment; and predict a proliferation of life science workspace

BioCity, the pioneering life science incubator and business collective today releases its biennial publication, the UK Life Science Start-Up Report, an in-depth analysis of emerging businesses within the life sciences across the UK.

November 19, 2019
·
4 min read
Deals

£1.2m investment to reinforce Stevenage Campus as world class cell and gene therapy hub

Hertfordshire Local Enterprise Partnership is to invest £1.2m into Stevenage Bioscience Catalyst (SBC) to help grow a world-class cell and gene therapy cluster.

November 19, 2019
·
4 min read
Drug Development

HHS and the American Society of Nephrology Launch $1.5 Million Phase 2 of Prize Competition to Redesign Dialysis

KidneyX seeks breakthrough solutions to transform kidney care

November 19, 2019
·
4 min read
Genetown

MilliporeSigma Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation

MilliporeSigma announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT resin, a first-to-market product used in biopharmaceutical manufacturing.

November 19, 2019
·
3 min read
Drug Development

Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development

TARA Biosystems, Inc. reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance.

November 19, 2019
·
3 min read
MorphoSys’ tafasitamab B-MIND DLBCL study successfully passed futility analysis

MorphoSys announced that the ongoing tafasitamab phase 3 B-MIND study has successfully passed the pre-planned, event-driven interim analysis for futility.

November 19, 2019
·
7 min read
Business

Thomas G. Heffner, Ph.D., Former Pfizer Executive, Joins Akelos Inc. as a Strategic Advisor; Akelos Inc. is a Biotechnology Company Developing Opioid Alternatives

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds Dr. Heffner, the former Executive Director of Neuroscience and Pain Business Development at Pfizer, as a Strategic Advisor.

November 19, 2019
·
3 min read
Business

ANANDA Scientific Forms Research Collaboration and License Agreement with Ben-Gurion University for Cannabinoid Products for Topical Applications

The research will focus on nanotechnology based CBD- products for the treatment of psoriasis and other diseases

November 19, 2019
·
4 min read